Optimal vaccination strategies for 2009 pandemic H1N1 and seasonal influenza vaccines in humans

Vaccine

Volumn 29, Issue 5, 2011, Pages 1009-1016

  Wu, Jiang ^a   Zhong, Xiang ^b   Li, Chris Ka fai ^c   Zhou, Jian fang ^d   Lu, Min ^a   Huang, Kuan Ying ^c   Dong, Mei ^a   Liu, Yan ^b   Luo, Feng Ji ^e   Du, Ning ^d   Chui, Cecilia ^c   Liu, Li Qi ^d   Smith, Nicola M G ^c   Li, Bo ^f   Shi, Nian Min ^e   Song, Li Fei ^b   Gao, Yan ^d   Wang, Da Yan ^d   Wang, Xu ^b   Zhu, Wen Fei ^d   Yan, Yan ^d   Li, Zi ^d   Chen, Jiang Ting ^b   McMichael, Andrew J ^c   Yin, Wei Dong ^b   Xu, Xiao Ning ^c   Shu, Yuelong ^d   more..

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b Sinovac Biotech Co Ltd   (China)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d National Institute for Viral Disease Control and Prevention   (China)

^e Chaoyang District Centre for Disease Control and Prevention   (China)

^f CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

B cell ELISPOT; Pandemic H1N1; Vaccine

Indexed keywords

2009 H1N1 INFLUENZA VACCINE; INFLUENZA VACCINE; SEASONAL INFLUENZA VACCINE; UNCLASSIFIED DRUG;

2009 H1N1 INFLUENZA; ADULT; ANGINA PECTORIS; ANTIBODY RESPONSE; ARTICLE; DRUG DOSE REGIMEN; DRUG DOSE SEQUENCE; DRUG INHIBITION; DRUG SAFETY; DRUG TOLERABILITY; ENZYME LINKED IMMUNOSPOT ASSAY; FATIGUE; HEADACHE; HEMAGGLUTINATION INHIBITION TEST; HUMAN; IMMUNIZATION; IMMUNOGENICITY; INJECTION SITE PAIN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEASONAL INFLUENZA; TREATMENT PLANNING;

ADOLESCENT; ADULT; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; B-LYMPHOCYTES; ENZYME-LINKED IMMUNOSPOT ASSAY; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; NEUTRALIZATION TESTS; VACCINATION; YOUNG ADULT;

EID: 78751575619     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.11.058     Document Type: Article

References (10)

1. Greenberg M.E., Lai M.H., Hartel G.F., Wichems C.H., Gittleson C., Bennet J., et al. Response to a monovalent 2009 influenza A (H1N1) vaccine. N Engl J Med 2009, 361(December (25)):2405-2413.
2. Zhu F.C., Wang H., Fang H.H., Yang J.G., Lin X.J., Liang X.F., et al. A novel influenza A (H1N1) vaccine in various age groups. N Engl J Med 2009, 361(December (25)):2414-2423.
3. Clark T.W., Pareek M., Hoschler K., Dillon H., Nicholson K.G., Groth N., et al. Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. N Engl J Med 2009, 361(December (25)):2424-2435.
4. Liang X.F., Wang H.Q., Wang J.Z., Fang H.H., Wu J., Zhu F.C., et al. Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet 2010, 375(9708):56-66.
5. Clutterbuck E.A., Oh S., Hamaluba M., Westcar S., Beverley P.C., Pollard A.J. Serotype-specific and age-dependent generation of pneumococcal polysaccharide-specific memory B-cell and antibody responses to immunization with a pneumococcal conjugate vaccine. Clin Vaccine Immunol 2008, 15(February (2)):182-193.
6. Vajo Z., Tamas F., Sinka L., Jankovics I. Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009-10 influenza season: a multicentre, randomised controlled trial. Lancet 2010, 375(9708):49-55.
7. Webster R.G. Original antigenic sin in ferrets: the response to sequential infections with influenza viruses. J Immunol 1966, 97(August (2)):177-183.
8. Virelizier J.L., Allison A.C., Schild G.C. Antibody responses to antigenic determinants of influenza virus hemagglutinin II. Original antigenic sin: a bone marrow-derived lymphocyte memory phenomenon modulated by thymus-derived lymphocytes. J Exp Med 1974, 140(December (6)):1571-1578.
9. Kim J.H., Skountzou I., Compans R., Jacob J. Original antigenic sin responses to influenza viruses. J Immunol 2009, 183(September (5)):3294-3301.
10. Nauta J.J., Beyer W.E., Osterhaus A.D. On the relationship between mean antibody level, seroprotection and clinical protection from influenza. Biologicals 2009, 37(August (4)):216-221.